)

Vitrolife (VITR) investor relations material
Vitrolife Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Consumables business achieved 9% organic growth in local currencies excluding discontinued business, outpacing market rates and driving share gains across all regions.
Organic growth in local currencies excluding discontinued business was 3% for both Q2 and H1 2025, despite significant currency headwinds.
Americas region delivered 5% organic growth in local currency, with share gains in genetic services despite a drop in IVF cycles due to US policy changes.
Strategic investment made as lead investor in AutoIVF, advancing the end-to-end IVF platform strategy.
Challenging quarter for the reproductive health industry due to US policy changes, currency headwinds, and macroeconomic uncertainty.
Financial highlights
Q2 net sales were SEK 871 million, down 7% in SEK due to an 8% negative currency effect; organic growth in local currencies, excluding discontinued business, was 3%.
Gross margin for Q2 was 58.0%, down from 59.9% year-over-year; EBITDA margin was 27.8%, down from 34.7%.
Q2 net income was SEK 100 million, with EPS at 0.74 SEK; H1 net income was SEK 199 million.
Operating cash flow for Q2 was SEK 151 million; H1 operating cash flow was SEK 220 million.
For H1 2025, net sales were SEK 1,714 million, down 4% in SEK, with organic growth of 3% in local currencies excluding discontinued business; H1 EBITDA was SEK 500 million.
Outlook and guidance
EMEA expected to remain solid, especially in Europe; Americas outlook depends on US IVF policy clarity, with pent-up demand likely to drive growth once resolved.
APAC outlook remains cautious due to mixed recovery and structural challenges, despite some government reimbursement improvements.
Focus on driving share gains, accelerating innovation, and operational excellence through digitalization and automation.
No formal guidance provided, but long-term targets are annual organic growth >10% in local currencies, EBITDA margin >33%, and net debt/EBITDA <3.
Monitoring macroeconomic and regulatory risks, including tariffs and the US IVF Executive Order.
Next Vitrolife earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage